NASDAQ:ESLA • US2975841048
ChartMill assigns a Buy % Consensus number of 83% to ESLA. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-09 | D. Boral Capital | Maintains | Buy -> Buy |
| 2026-01-28 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-11-03 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-12 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-03 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-29 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-02-21 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-02-18 | D. Boral Capital | Initiate | Buy |
7 analysts have analysed ESLA and the average price target is 8.16 USD. This implies a price increase of 615.79% is expected in the next year compared to the current price of 1.14.
The consensus rating for ESTRELLA IMMUNOPHARMA INC (ESLA) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.